Sofdra US Sales Curve, page-29

700 USD sales price ~ 1000 AUD per script
20% profit assumption ( after tax, expenses, royalty payment, reimbursement )
200 AUD profit per script.

Kaken first month 2 months sales ~ 34,867 ~ 209,202 annual script rate in first 2 months of sales.
209,202 X 200 AUD profit = 41.8 Million Profit ( year 1 )

US average is 2 x the script renewals as Japan
41.8 x 2 = 83.7 million ( script renewal adjustment )

US has 3x the population with disease, and same occurance rates
83.7 x 3 = 251 Million AUD profit.

PE 15:1 Market cap ~ 3.76 Billion
Current Market cap 714 Million ( 39.5 cents )
SP Adjusted price $2.08 AUD

No calculation for greater penetration then Kaken
No calculation for greater script renewals than US average of 2.

Script renewal adjustment ( 4 scripts instead of 2 )
SP Adjusted price $4.16 AUD

Plenty of room for BOT to knock this into outer space.